APA (7th ed.) Citation

Mastanzade, M., Çelik, M. M. Ö., Erdem, S., Özbalak, M. M., Hindilerden, İ. Y., Yenerel, M. N., & Beşışık, S. K. A SINGLE-CENTER REAL-LIFE EXPERIENCE WITH FIRST-LINE DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE (DARA-VCD) IN AL AMYLOIDOSIS. Elsevier.

Chicago Style (17th ed.) Citation

Mastanzade, Metban, Meryem Merve Ören Çelik, Simge Erdem, Mustafa Murat Özbalak, İpek Yönal Hindilerden, Mustafa Nuri Yenerel, and Sevgi Kalayoğlu Beşışık. A SINGLE-CENTER REAL-LIFE EXPERIENCE WITH FIRST-LINE DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE (DARA-VCD) IN AL AMYLOIDOSIS. Elsevier.

MLA (9th ed.) Citation

Mastanzade, Metban, et al. A SINGLE-CENTER REAL-LIFE EXPERIENCE WITH FIRST-LINE DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE (DARA-VCD) IN AL AMYLOIDOSIS. Elsevier.